Mandaue, Baby Boy .
HRN: 27-78-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/22/2025
09/29/2025
IV
55mg
Q24
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes